Novo weight loss drug trial shows improvement in fatty liver disease
Novo Nordisk said Friday that its weight-loss drug achieved the primary goal of a late-stage study in patients with fatty liver disease, reducing scarring of the organ without worsening the condition.
ENTRADAS POPULARES
Thousands left without power in Washington State
noviembre 21, 2024
Eight times as many children will face extreme heatwaves in 2050
noviembre 21, 2024
Elton John’s Tammy Faye to close on Broadway
noviembre 21, 2024
TRANSMISIÓN EN VIVO